Seeman-Lodding H, Häggmark S, Jern C, Jern S, Johansson G, Winsö O, Biber B
Department of Anesthesiology and Intensive Care, Sahlgrenska University Hospital, Göteborg, Sweden.
Acta Anaesthesiol Scand. 1999 Jul;43(6):623-33. doi: 10.1034/j.1399-6576.1999.430606.x.
Endothelium-derived tissue-type plasminogen activator, t-PA, is the key enzyme in the initiation of endogenous thrombolysis. Plasma levels of t-PA increase in response to sympatho-adrenergic activation. In the mesenteric vascular bed an increased norepinephrine spillover has been observed during positive end-expiratory pressure ventilation, PEEP. This experimental study examines the effects of PEEP-induced alterations on regional release rates and systemic levels of t-PA in vivo.
The protocol included measurements of arterio-venous concentration gradients of t-PA and the respective plasma flow across the pulmonary, coronary, hepatic and preportal vascular beds, in pigs, during zero-PEEP and at 2, 4 and 10 min after the application of a PEEP of 10 cm H2O. Both total plasma t-PA antigen (ELISA with a porcine t-PA standard) and active t-PA (spectrophotometric functional assay) were determined.
During zero-PEEP, a high preportal basal net release and hepatic net uptake of total t-PA was observed. With PEEP, the magnitude of the preportal net release of t-PA was markedly enhanced (+24+/-5%), as was hepatic net uptake (+21+/-8%), simultaneously to a significant decrease in liver plasma flow (-30+/-2%). PEEP-induced alterations in active t-PA mirrored those observed in total t-PA. No significant net fluxes of total or active t-PA were observed across the coronary or the pulmonary vascular beds.
Clinically used levels of PEEP induce increases in net release of endothelially derived t-PA within preportal organs. The application of PEEP is associated with increased systemic levels of total and active t-PA, in spite of a simultaneous increase in hepatic net uptake, indicating that the preportal vascular bed can not account for the systemic t-PA response.
内皮细胞源性组织型纤溶酶原激活剂(t-PA)是内源性溶栓启动的关键酶。t-PA的血浆水平会因交感-肾上腺素能激活而升高。在肠系膜血管床,呼气末正压通气(PEEP)期间观察到去甲肾上腺素溢出增加。本实验研究旨在探讨PEEP诱导的改变对体内t-PA区域释放率和全身水平的影响。
该方案包括在零PEEP以及施加10 cm H₂O的PEEP后2、4和10分钟时,测量猪肺、冠状动脉、肝脏和门静脉前血管床的t-PA动静脉浓度梯度以及相应的血浆流量。同时测定总血浆t-PA抗原(使用猪t-PA标准品的ELISA法)和活性t-PA(分光光度功能测定法)。
在零PEEP期间,观察到门静脉前总t-PA有较高的基础净释放和肝脏净摄取。使用PEEP时,门静脉前t-PA的净释放量显著增加(+24±5%),肝脏净摄取量也增加(+21±8%),同时肝血浆流量显著减少(-30±2%)。PEEP诱导的活性t-PA变化与总t-PA的变化一致。在冠状动脉或肺血管床未观察到总t-PA或活性t-PA的显著净通量。
临床使用的PEEP水平可诱导门静脉前器官内皮源性t-PA的净释放增加。尽管肝脏净摄取同时增加,但PEEP的应用与总t-PA和活性t-PA的全身水平升高有关,这表明门静脉前血管床不能解释全身t-PA的反应。